Investor Relations
The primary objective of the Investor Relations activities of Merck KGaA, Darmstadt, Germany, is to communicate with the financial
community, especially private as well as institutional investors and analysts, in an open and timely manner. Conducting a
correct, comprehensive and fair dialogue, you find all information on the EMD Group website www.merck.de.
"EMD is an innovative pharmaceutical and chemical company with a portfolio of complementary business dynamics that will drive
the quality growth of the Group going forward."
Dr. Michael Becker
Dr. Michael Becker
IR NEWS
02/18/2009Merck KGaA: 2008 Operating Result Rises 16% to € 1,131 Million
UPCOMING DATES
02/18/2009Publication of business results for Q4/FY 2008 (Analyst Conference)
